Eastman Chemical (EMN) Liabilities and Shareholders Equity (2009 - 2026)

Eastman Chemical has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $15.4 billion in Q2 2026.

• Liabilities and Shareholders Equity for Q2 2026 came in at $15.4 billion, up 1.35% year-over-year; the trailing twelve-month figure through Jun 2026 was $60.5 billion (changed 0.03% YoY), and the FY2025 annual result was $14.9 billion, down 2.33% from the prior year.
• Liabilities and Shareholders Equity climbed to $15.4 billion in Q2 2026, from $15.2 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $15.8 billion in Q1 2022 and troughed at $14.6 billion in Q3 2023.
• A 5-year average of $15.0 billion and a median of $15.0 billion in 2025 frame the typical range for Liabilities and Shareholders Equity.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity fell 7.84%; it then climbed 3.96% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $14.7 billion in 2022, then retreated by 0.23% to $14.6 billion in 2023, then gained by 3.96% to $15.2 billion in 2024, then fell by 2.33% to $14.9 billion in 2025, then advanced by 3.8% to $15.4 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $15.4 billion in Q2 2026, $15.2 billion in Q1 2026, and $14.9 billion in Q4 2025.